Hou LS

No ORCID on file · 1 paper in corpus · active 2017
2017
Scientific reports ·doi:10.1038/s41598-017-08249-7

Type I epithelial ovarian cancer (EOC) is primarily resistant to platinum-based chemotherapies and needs novel therapeutics. Given the aberrant Wnt activation in type I EOC and the involvement of Dapper1 Antagonist of Catenin-1 (DACT1) in W…